Selected research
Industry Growth & Trends
Global CMC Biosafety Testing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global CMC Biosafety Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for CMC Biosafety Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for CMC Biosafety Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CMC Biosafety Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the CMC Biosafety Testing market include WuXi Biologics, Wuhan Canvest Biotechnology, Centre Testing International (CTI), Suzhou Liangchen Biotechnology, JADE Biomedical, Standard Testing Group, Sino Tech World Biologicals, Q2 Solutions and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global CMC Biosafety Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The CMC Biosafety Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global CMC Biosafety Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to CMC Biosafety Testing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global CMC Biosafety Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
CMC Biosafety Testing Market by Company
WuXi Biologics
Wuhan Canvest Biotechnology
Centre Testing International (CTI)
Suzhou Liangchen Biotechnology
JADE Biomedical
Standard Testing Group
Sino Tech World Biologicals
Q2 Solutions
Merck
Charles River Laboratories
Sartorius
Eurofins Scientific
CAS Testing Technical Services
SGS
Samsung Biologics
NTEK
Texcell
Sino Biological
Miracle Points
Suzhou Cefety Bioscience
Zhejiang Hengyu Biological
CMC Biosafety Testing Segment by Type
Raw Materials
Viral Banks
Cell Banks
Others
CMC Biosafety Testing Segment by Application
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Academic and Research Institutions
CMC Biosafety Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CMC Biosafety Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CMC Biosafety Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CMC Biosafety Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of CMC Biosafety Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Raw Materials
- Viral Banks
- Cell Banks
- Others
Applications
- Pharmaceutical and Biotechnology Companies
- CROs and CDMOs
- Academic and Research Institutions
Companies covered
- WuXi Biologics
- Wuhan Canvest Biotechnology
- Centre Testing International (CTI)
- Suzhou Liangchen Biotechnology
- JADE Biomedical
- Standard Testing Group
- Sino Tech World Biologicals
- Q2 Solutions
- Merck
- Charles River Laboratories
- Sartorius
- Eurofins Scientific
- CAS Testing Technical Services
- SGS
- Samsung Biologics
- NTEK
- Texcell
- Sino Biological
- Miracle Points
- Suzhou Cefety Bioscience
- Zhejiang Hengyu Biological
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global CMC Biosafety Testing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global CMC Biosafety Testing Market Size by Region (2021-2032)
- 1.4.1 Global CMC Biosafety Testing Market Size by Region (2021-2026)
- 1.4.2 Global CMC Biosafety Testing Market Size by Region (2027-2032)
- 1.5 Key Regions CMC Biosafety Testing Market Size (2021-2032)
- 1.5.1 North America CMC Biosafety Testing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe CMC Biosafety Testing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific CMC Biosafety Testing Market Size Growth Rate (2021-2032)
- 1.5.4 South America CMC Biosafety Testing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa CMC Biosafety Testing Market Size Growth Rate (2021-2032)
2 CMC Biosafety Testing Market by Type
- 2.1 Type Introduction
- 2.1.1 Raw Materials
- 2.1.2 Viral Banks
- 2.1.3 Cell Banks
- 2.1.4 Others
- 2.2 Global CMC Biosafety Testing Market Size by Type
- 2.2.1 Global CMC Biosafety Testing Market Size Overview by Type (2021-2032)
- 2.2.2 Global CMC Biosafety Testing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global CMC Biosafety Testing Market Size Forecasted by Type (2027-2032)
- 2.3 Global CMC Biosafety Testing Market Size by Regions
- 2.3.1 North America CMC Biosafety Testing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe CMC Biosafety Testing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific CMC Biosafety Testing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America CMC Biosafety Testing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa CMC Biosafety Testing Market Size Breakdown by Type (2021-2026)
3 CMC Biosafety Testing Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical and Biotechnology Companies
- 3.1.2 CROs and CDMOs
- 3.1.3 Academic and Research Institutions
- 3.2 Global CMC Biosafety Testing Market Size by Application
- 3.2.1 Global CMC Biosafety Testing Market Size Overview by Application (2021-2032)
- 3.2.2 Global CMC Biosafety Testing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global CMC Biosafety Testing Market Size Forecasted by Application (2027-2032)
- 3.3 Global CMC Biosafety Testing Market Size by Regions
- 3.3.1 North America CMC Biosafety Testing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe CMC Biosafety Testing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific CMC Biosafety Testing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America CMC Biosafety Testing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa CMC Biosafety Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 CMC Biosafety Testing Industry Trends
- 4.2 CMC Biosafety Testing Industry Drivers
- 4.3 CMC Biosafety Testing Industry Opportunities and Challenges
- 4.4 CMC Biosafety Testing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by CMC Biosafety Testing Revenue (2021-2026)
- 5.2 Global CMC Biosafety Testing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global CMC Biosafety Testing Key Company Headquarters & Area Served
- 5.4 Global CMC Biosafety Testing Company, Product Type & Application
- 5.5 Global CMC Biosafety Testing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global CMC Biosafety Testing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 CMC Biosafety Testing Players Market Share by Revenue in 2025
- 5.6.3 2025 CMC Biosafety Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 WuXi Biologics
- 6.1.1 WuXi Biologics Company Information
- 6.1.2 WuXi Biologics Business Overview
- 6.1.3 WuXi Biologics CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 WuXi Biologics CMC Biosafety Testing Product Portfolio
- 6.1.5 WuXi Biologics Recent Developments
- 6.2 Wuhan Canvest Biotechnology
- 6.2.1 Wuhan Canvest Biotechnology Company Information
- 6.2.2 Wuhan Canvest Biotechnology Business Overview
- 6.2.3 Wuhan Canvest Biotechnology CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Wuhan Canvest Biotechnology CMC Biosafety Testing Product Portfolio
- 6.2.5 Wuhan Canvest Biotechnology Recent Developments
- 6.3 Centre Testing International (CTI)
- 6.3.1 Centre Testing International (CTI) Company Information
- 6.3.2 Centre Testing International (CTI) Business Overview
- 6.3.3 Centre Testing International (CTI) CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Centre Testing International (CTI) CMC Biosafety Testing Product Portfolio
- 6.3.5 Centre Testing International (CTI) Recent Developments
- 6.4 Suzhou Liangchen Biotechnology
- 6.4.1 Suzhou Liangchen Biotechnology Company Information
- 6.4.2 Suzhou Liangchen Biotechnology Business Overview
- 6.4.3 Suzhou Liangchen Biotechnology CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Suzhou Liangchen Biotechnology CMC Biosafety Testing Product Portfolio
- 6.4.5 Suzhou Liangchen Biotechnology Recent Developments
- 6.5 JADE Biomedical
- 6.5.1 JADE Biomedical Company Information
- 6.5.2 JADE Biomedical Business Overview
- 6.5.3 JADE Biomedical CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 JADE Biomedical CMC Biosafety Testing Product Portfolio
- 6.5.5 JADE Biomedical Recent Developments
- 6.6 Standard Testing Group
- 6.6.1 Standard Testing Group Company Information
- 6.6.2 Standard Testing Group Business Overview
- 6.6.3 Standard Testing Group CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Standard Testing Group CMC Biosafety Testing Product Portfolio
- 6.6.5 Standard Testing Group Recent Developments
- 6.7 Sino Tech World Biologicals
- 6.7.1 Sino Tech World Biologicals Company Information
- 6.7.2 Sino Tech World Biologicals Business Overview
- 6.7.3 Sino Tech World Biologicals CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Sino Tech World Biologicals CMC Biosafety Testing Product Portfolio
- 6.7.5 Sino Tech World Biologicals Recent Developments
- 6.8 Q2 Solutions
- 6.8.1 Q2 Solutions Company Information
- 6.8.2 Q2 Solutions Business Overview
- 6.8.3 Q2 Solutions CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Q2 Solutions CMC Biosafety Testing Product Portfolio
- 6.8.5 Q2 Solutions Recent Developments
- 6.9 Merck
- 6.9.1 Merck Company Information
- 6.9.2 Merck Business Overview
- 6.9.3 Merck CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Merck CMC Biosafety Testing Product Portfolio
- 6.9.5 Merck Recent Developments
- 6.10 Charles River Laboratories
- 6.10.1 Charles River Laboratories Company Information
- 6.10.2 Charles River Laboratories Business Overview
- 6.10.3 Charles River Laboratories CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Charles River Laboratories CMC Biosafety Testing Product Portfolio
- 6.10.5 Charles River Laboratories Recent Developments
- 6.11 Sartorius
- 6.11.1 Sartorius Company Information
- 6.11.2 Sartorius Business Overview
- 6.11.3 Sartorius CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Sartorius CMC Biosafety Testing Product Portfolio
- 6.11.5 Sartorius Recent Developments
- 6.12 Eurofins Scientific
- 6.12.1 Eurofins Scientific Company Information
- 6.12.2 Eurofins Scientific Business Overview
- 6.12.3 Eurofins Scientific CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Eurofins Scientific CMC Biosafety Testing Product Portfolio
- 6.12.5 Eurofins Scientific Recent Developments
- 6.13 CAS Testing Technical Services
- 6.13.1 CAS Testing Technical Services Company Information
- 6.13.2 CAS Testing Technical Services Business Overview
- 6.13.3 CAS Testing Technical Services CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 CAS Testing Technical Services CMC Biosafety Testing Product Portfolio
- 6.13.5 CAS Testing Technical Services Recent Developments
- 6.14 SGS
- 6.14.1 SGS Company Information
- 6.14.2 SGS Business Overview
- 6.14.3 SGS CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 SGS CMC Biosafety Testing Product Portfolio
- 6.14.5 SGS Recent Developments
- 6.15 Samsung Biologics
- 6.15.1 Samsung Biologics Company Information
- 6.15.2 Samsung Biologics Business Overview
- 6.15.3 Samsung Biologics CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Samsung Biologics CMC Biosafety Testing Product Portfolio
- 6.15.5 Samsung Biologics Recent Developments
- 6.16 NTEK
- 6.16.1 NTEK Company Information
- 6.16.2 NTEK Business Overview
- 6.16.3 NTEK CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 NTEK CMC Biosafety Testing Product Portfolio
- 6.16.5 NTEK Recent Developments
- 6.17 Texcell
- 6.17.1 Texcell Company Information
- 6.17.2 Texcell Business Overview
- 6.17.3 Texcell CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Texcell CMC Biosafety Testing Product Portfolio
- 6.17.5 Texcell Recent Developments
- 6.18 Sino Biological
- 6.18.1 Sino Biological Company Information
- 6.18.2 Sino Biological Business Overview
- 6.18.3 Sino Biological CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Sino Biological CMC Biosafety Testing Product Portfolio
- 6.18.5 Sino Biological Recent Developments
- 6.19 Miracle Points
- 6.19.1 Miracle Points Company Information
- 6.19.2 Miracle Points Business Overview
- 6.19.3 Miracle Points CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Miracle Points CMC Biosafety Testing Product Portfolio
- 6.19.5 Miracle Points Recent Developments
- 6.20 Suzhou Cefety Bioscience
- 6.20.1 Suzhou Cefety Bioscience Company Information
- 6.20.2 Suzhou Cefety Bioscience Business Overview
- 6.20.3 Suzhou Cefety Bioscience CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Suzhou Cefety Bioscience CMC Biosafety Testing Product Portfolio
- 6.20.5 Suzhou Cefety Bioscience Recent Developments
- 6.21 Zhejiang Hengyu Biological
- 6.21.1 Zhejiang Hengyu Biological Company Information
- 6.21.2 Zhejiang Hengyu Biological Business Overview
- 6.21.3 Zhejiang Hengyu Biological CMC Biosafety Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Zhejiang Hengyu Biological CMC Biosafety Testing Product Portfolio
- 6.21.5 Zhejiang Hengyu Biological Recent Developments
7 North America
- 7.1 North America CMC Biosafety Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America CMC Biosafety Testing Market Size by Country (2021-2026)
- 7.3 North America CMC Biosafety Testing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe CMC Biosafety Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe CMC Biosafety Testing Market Size by Country (2021-2026)
- 8.3 Europe CMC Biosafety Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific CMC Biosafety Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific CMC Biosafety Testing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific CMC Biosafety Testing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America CMC Biosafety Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America CMC Biosafety Testing Market Size by Country (2021-2026)
- 10.3 South America CMC Biosafety Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa CMC Biosafety Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa CMC Biosafety Testing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa CMC Biosafety Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst